Canada Pension Plan Investment Board’s Supernus Pharmaceuticals SUPN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$998K	Buy	19,300 +500	+3%	+$25.5K	﹤0.01%	1016
2025 Q4	$934K	Buy	18,800 +16,300	+652%	+$793K	﹤0.01%	1091
2025 Q3	$119K	Sell	2,500 -1,000	-29%	-$40.3K	﹤0.01%	1177
2025 Q2	$110K	Sell	3,500 -3,800	-52%	-$122K	﹤0.01%	1171
2025 Q1	$239K	Buy	7,300 +4,600	+170%	+$163K	﹤0.01%	1032
2024 Q4	$97.6K	Sell	2,700 -59,000	-96%	-$2.08M	﹤0.01%	1255
2024 Q3	$1.92M	Buy	+61,700	New	+$1.93M	﹤0.01%	874
2019 Q2	–	Sell	-88,300	Closed	-$3.09M	–	1464
2019 Q1	$3.09M	Buy	+88,300	New	+$3.29M	0.01%	907

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Pension Plan Investment Board's SUPN Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Supernus Pharmaceuticals (SUPN) stake by 2.7% in Q1 2026, buying an estimated $25.5K and bringing the position to 19,300 shares worth $998K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Canada Pension Plan Investment Board first reported a position in SUPN in Q1 2019 and has held it in 8 quarters since. The position peaked at $3.09M in Q1 2019. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

Canada Pension Plan Investment Board held 19,300 shares of Supernus Pharmaceuticals worth $998K as of Q1 2026.
Canada Pension Plan Investment Board bought 500 Supernus Pharmaceuticals shares in Q1 2026, an estimated $25.5K.
Supernus Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1016 holding.
Canada Pension Plan Investment Board first reported a position in Supernus Pharmaceuticals in Q1 2019 and has held it in 8 quarters since.
Canada Pension Plan Investment Board's Supernus Pharmaceuticals position peaked at $3.09M in Q1 2019.
327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.